Top Clinical Trials companies in Poland by Price to Sales Ratio (P/S)
Poland
# |
Name |
Price to Sales Ratio (P/S) |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
1,481,211.88 |
Feb. 3, 2025 | USD 2.23 | -2.90% |
|
Poland |
|
| 2 |
202.26 |
Feb. 3, 2025 | USD 1.79 | -1.96% |
|
Poland |
|
| 3 |
125.32 |
Feb. 3, 2025 | USD 9.53 | 2.20% |
|
Poland |
|
| 4 |
16.99 |
Feb. 3, 2025 | USD 12.20 | -4.46% |
|
Poland |
|
| 5 |
12.71 |
Feb. 3, 2025 | USD 6.53 | 2.36% |
|
Poland |
|
| 6 |
2.19 |
Feb. 3, 2025 | USD 10.51 | -3.97% |
|
Poland |
Frequently Asked Questions
-
Which Clinical Trials company in Poland has the highest Price to Sales Ratio (P/S) ?
The Clinical Trials company in Poland with the highest Price to Sales Ratio (P/S) is Molecure S.A. (Warsaw Stock Exchange: MOC.WA) at 1,481,211.88.
-
Which Clinical Trials company in Poland has the lowest Price to Sales Ratio (P/S) ?
The Clinical Trials company in Poland with the lowest Price to Sales Ratio (P/S) is Selvita S.A. (Warsaw Stock Exchange: SLV.WA) at 2.19.
-
What are the top 10 Clinical Trials companies in Poland by Price to Sales Ratio (P/S) ?
The top 10 Clinical Trials companies in Poland by Price to Sales Ratio (P/S) are Molecure S.A., Medinice S.A., Poltreg S.A., Captor Therapeutics Spolka Akcyjna, Ryvu Therapeutics S.A. and Selvita S.A..
-
What are the bottom 10 Clinical Trials companies in Poland by Price to Sales Ratio (P/S) ?
The bottom 10 Clinical Trials companies in Poland by Price to Sales Ratio (P/S) are Selvita S.A., Ryvu Therapeutics S.A., Captor Therapeutics Spolka Akcyjna, Poltreg S.A., Medinice S.A. and Molecure S.A..
